povidone-iodine has been researched along with Phlebitis* in 4 studies
2 trial(s) available for povidone-iodine and Phlebitis
Article | Year |
---|---|
Comparing the Effects of Sesame Oil vs. Nitroglycerin Ointment on the Incidence of Chemotherapy-Induced Phlebitis: A Single Blind Clinical Trial.
Phlebitis is a severe inflammatory response in patients undergoing chemotherapy that can lead to complications and increased length of hospitalization.. This study was conducted to examine the effects of sesame oil and nitroglycerin ointment on the incidence of chemotherapy-induced phlebitis in patients with cancer. Methods: This clinical trial study involved 138 cancer patients who were randomly assigned into three groups. The three groups received nitroglycerin ointment, sesame oil, or betadine alcoholic solution that were applied on the distal catheter area at a length of 1.5 centimeters and width of 2 × 4 cm using graded paper. The site was then dressed and fixed with anti-allergenic adhesives. The research samples were examined for 72 hours for the incidence of phlebitis.. No statistically significant difference was observed between the incidence of phlebitis in the sesame oil, nitroglycerin ointment and alcohol-betadine groups in the first 24 hours (p=0.2), the second 24 hours (p=0.13) and the third 24 hours (p=0.13).. External use of both sesame oil and nitroglycerin is effective in reducing chemotherapy-induced phlebitis. Due to its anti-inflammatory effect and low cost, however, using sesame oil is recommended. Topics: Administration, Topical; Antineoplastic Agents; Humans; Incidence; Nitroglycerin; Ointments; Phlebitis; Povidone-Iodine; Sesame Oil; Single-Blind Method | 2023 |
An evaluation of dextranomer as a cleansing agent in the treatment of the post-phlebitic stasis ulcer.
Recent reports in the literature have indicated that dextranomer (Debrisan; Adcock-Ingram) is an effective cleansing agent for the secreting wound. To evaluate its possible use in the initial cleansing of the infected secreting stasis ulcer, 100 patients were incorporated in a single-blind randomized trial. The mean cleansing time for the Debrisan-treated ulcers was 5,9 days, compared with 15,4 days for the control group receiving standard treatment. The average healing time for ulcers treated with Debrisan and left to heal spontaneously was 4,4 weeks compared with 5,32 weeks for the controls. Debrisan, furthermore, decreased the amount of local tissue oedema and alleviated local pain in the majority of patients. It is feasible to use Debrisan for outpatient treatment and without additional staff in a busy clinic. The cost of Debrisan therapy appeared to be reasonable. A hydrophilic cleansing agent such as Debrisan has a definite place in the early treatment of the secreting infected post-phlebitic stasis ulcer. Topics: Chlorohydrins; Clinical Trials as Topic; Debridement; Dextrans; Edema; Epichlorohydrin; Female; Granulation Tissue; Humans; Male; Pain; Phlebitis; Povidone-Iodine; Random Allocation; Time Factors; Varicose Ulcer; Wound Healing | 1980 |
2 other study(ies) available for povidone-iodine and Phlebitis
Article | Year |
---|---|
Complications with heparin-lock needles.
The incidence of phlebitis was determined for heparin-lock needles after use of three different methods of skin preparation and follow-up care. Phlebitis was significantly more frequent when iodophor solution and iodophor ointment, respectively, were used than when iodophor solution alone was used for heparin-lock needles in use longer than 48 hours, with more than ten manipulations of the systems, and when only one drug was infused through the systems. Iodophor solution skin preparation followed by daily application of iodophor solution is recommended to minimize the occurrence of associated phlebitis. Topics: 1-Propanol; Administration, Topical; Asepsis; Humans; Infections; Infusions, Parenteral; Methods; Needles; Phlebitis; Povidone-Iodine | 1979 |
The importance of frequent examination of infusion sites in preventing postinfusion phlebitis.
Topics: Bacterial Infections; Humans; Infusions, Parenteral; Phlebitis; Povidone-Iodine | 1977 |